Citi Pharma Balance Sheet Health
Financial Health criteria checks 5/6
Citi Pharma has a total shareholder equity of PKR5.4B and total debt of PKR1.8B, which brings its debt-to-equity ratio to 34.1%. Its total assets and total liabilities are PKR10.0B and PKR4.6B respectively. Citi Pharma's EBIT is PKR1.2B making its interest coverage ratio 10.6. It has cash and short-term investments of PKR1.6B.
Key information
34.1%
Debt to equity ratio
PK₨1.83b
Debt
Interest coverage ratio | 10.6x |
Cash | PK₨1.58b |
Equity | PK₨5.37b |
Total liabilities | PK₨4.61b |
Total assets | PK₨9.98b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: CPHL's short term assets (PKR6.6B) exceed its short term liabilities (PKR4.5B).
Long Term Liabilities: CPHL's short term assets (PKR6.6B) exceed its long term liabilities (PKR158.1M).
Debt to Equity History and Analysis
Debt Level: CPHL's net debt to equity ratio (4.7%) is considered satisfactory.
Reducing Debt: CPHL's debt to equity ratio has reduced from 72.5% to 34.1% over the past 5 years.
Debt Coverage: CPHL's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: CPHL's interest payments on its debt are well covered by EBIT (10.6x coverage).